Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections.

Kimmig LM, Wu D, Gold M, Pettit NN, Pitrak D, Mueller J, Husain AN, Mutlu EA, Mutlu GM. IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections. medRxiv. 2020 Sep 12.

View in: PubMed